Literature DB >> 32267470

Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up.

Mehmet Kanbay1, Nicolas Girerd2, Jean-Loup Machu2, Erwan Bozec2, Kevin Duarte2, Jean-Marc Boivin2, Sandra Wagner2, João Pedro Ferreira2, Faiez Zannad2, Patrick Rossignol2.   

Abstract

BACKGROUND: Recent studies have shown that hyperuricemia may be associated with incident hypertension (HTN). We examined whether serum uric acid (SUA) is a predictor of HTN and target organ damage (TOD) 20 years later in initially healthy middle-aged individuals.
METHODS: Participants from the Suivi Temporaire Annuel Non-Invasif de la Santé des Lorrains Assurés Sociaux (STANISLAS) a single-center familial longitudinal cohort study (961 initially healthy adults and 570 children) underwent clinical and laboratory measurements at baseline and after approximately 20 years. Blood pressure (BP: using ambulatory BP measurements), urine albumin-to-creatinine ratio, estimated glomerular filtration rate (eGFR), left ventricular hypertrophy (LVH), diastolic dysfunction, and carotid-femoral pulse wave velocity (PWV) were measured at the end of follow-up.
RESULTS: In the parent population, higher baseline or last SUA levels and higher change in SUA (ΔUA) were significantly associated with an increased risk of HTN development, even after adjusting for known HTN risk factors (all P < 0.01). Higher baseline SUA was marginally associated with an increased risk of having high carotid-femoral PWV (P = 0.05). The association of SUA with BP increase was body mass index dependent (the increase in BP being greater in leaner subjects; interactionp < 0.05), and the association of SUA with eGFR decline was age dependent (the decline in eGFR being greater in older subjects; interactionp < 0.05). There was no significant association between SUA and diastolic dysfunction or LVH. In the whole population (i.e. including children), a significant association between SUA at baseline and the risk of HTN and higher carotid-femoral PWV was also found (both P < 0.02).
CONCLUSIONS: Increased SUA is associated with the development of HTN and vascular/renal TOD in initially healthy midlife subjects. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  albuminuria; blood pressure; chronic kidney disease; hypertension; left ventricular hypertrophy; pulse wave velocity; uric acid

Year:  2020        PMID: 32267470     DOI: 10.1093/ajh/hpaa030

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

1.  Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.

Authors:  Mehmet Kanbay; Constance Xhaard; Edith Le Floch; Claire Dandine-Roulland; Nicolas Girerd; João Pedro Ferreira; Jean-Marc Boivin; Sandra Wagner; Delphine Bacq-Daian; Jean-François Deleuze; Faiez Zannad; Patrick Rossignol
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

2.  Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study.

Authors:  Xiaoli Yang; Bingqing Zhou; Li Zhou; Liufu Cui; Jing Zeng; Shuo Wang; Weibin Shi; Ye Zhang; Xiaoli Luo; Chunmei Xu; Yuanzheng Xue; Hao Chen; Shuohua Chen; Guodong Wang; Li Guo; Pedro A Jose; Christopher S Wilcox; Shouling Wu; Gengze Wu; Chunyu Zeng
Journal:  Front Cardiovasc Med       Date:  2022-03-10

3.  Uric acid and arterial stiffness in children and adolescents: Role of insulin resistance and blood pressure.

Authors:  Simonetta Genovesi; Laura Montelisciani; Francesca Viazzi; Marco Giussani; Giulia Lieti; Ilenia Patti; Antonina Orlando; Laura Antolini; Paolo Salvi; Gianfranco Parati
Journal:  Front Cardiovasc Med       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.